|1.||Meyer, Linda M: 1 article (10/2015)|
|2.||Schönfeld, Carl-Ludwig: 1 article (10/2015)|
|3.||Wegener, Alfred R: 1 article (10/2015)|
|4.||Sun, Jianfei: 1 article (09/2015)|
|5.||Wang, Fengshan: 1 article (09/2015)|
|6.||Huang, Siling: 1 article (09/2015)|
|7.||Guo, Xueping: 1 article (09/2015)|
|8.||Park, Jung-Won: 1 article (05/2013)|
|9.||Park, Sang-Woo: 1 article (05/2013)|
|10.||Kim, Hwang-Gyun: 1 article (05/2013)|
08/01/1997 - "Our findings suggest that bismuth carbomer enemas are safe and effective in achieving and maintaining remission in patients with treatment-resistant chronic pouchitis."
08/01/1997 - "To determine the safety and efficacy of bismuth carbomer enemas in achieving and maintaining remission in treatment-resistant chronic pouchitis. "
08/01/1997 - "Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis."
01/01/2000 - "Bismuth carbomer foam enemas may not be an effective therapy for chronic active pouchitis. "
02/01/1999 - "Bismuth carbomer foam enemas are not effective therapy for active chronic pouchitis. "
|2.||Dry Eye Syndromes (Dry Eye Syndrome)
01/01/2010 - "A 4-week, prospective, randomized, parallel-group, comparative, noninferiority study was conducted at the Taipei Medical University Hospital (Taipei, Taiwan) in patients with dry eye syndrome who were randomly assigned to 1 of 2 treatment groups: the carbomer-based lipid-containing (CBLC) gel group and the HP-guar gel group. "
09/01/1997 - "Carbomer gel was more efficacious than was placebo in improving a number of subjective and objective symptoms of moderate-to-severe dry eye syndrome. "
09/01/1997 - "Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome."
01/01/1991 - "The appearance on the French market of a carbomer tear substitute, Gel-Larmes, an original galenic form, constitutes a real therapeutic progress in the treatment of dry eye syndrome. "
07/01/2011 - "Results. Carbomer drop was effective in prophylaxis of dry eye syndrome in only three of 18 patients, whereas polyethylene cover showed greater effect in 18 of 18 eyes at the end of the study (SD 0·3835, Z = -3·873, p < 0·001). "
|3.||Wounds and Injuries (Trauma)
12/01/2004 - "0.1 g of cross-linking polyacrylic resin (carbomer cream) without adenovirus was daubed onto the wounds in A group, and the same amount of carbomer cream with adenovirus in titers of 5 x 10(9)/L was daubed onto the wounds in B group, while no treatment was given in C group. "
04/01/2012 - "Gel formulations (12.5% and 100% v/w Aloe mucilage in a carbomer base) were applied topically (500 mg once daily) for 24 days in the thermal wound model. "
01/01/2006 - "Clinical results also show clean, well-debrided wounds, an effect that (in the absence of an established model for wound cleansing) was traced to the hydrogel component carbomer. "
09/01/2015 - "As a new type of hydrogel matrix, HA is superior to carbomer and sodium alginate if it is used in wound caring preparations."
02/01/2013 - "Wounds were treated with carbomer blank gel in groups A and B, with insulin composite gel in group C, with NGF gel in group D, and with NGF-insulin composite gel in group E, once a day. "
03/01/2002 - "[A study of experimental carbomer glaucoma and other experimental glaucoma in rabbits]."
08/01/2010 - "Experimental glaucoma model was induced by intracameral injection of compound Carbomer solution in rabbits. "
03/01/2002 - "Experimental glaucoma model induced by carbomer has the advantages of producing moderate and sustained IOP elevation. "
03/01/2002 - "The rabbits were divided randomly into 4 groups: I, II, III and IV. Anterior chamber injection of 0.1 ml of 0.3% carbomer (I), 0.2 ml of methylcellulose (II), 0.2 ml of compound methylcellulose (III) and subconjunctival injection of 5 mg of dexamethasone (IV) were performed respectively on them to induce glaucoma. "
02/01/2012 - "The clinically used sulfonamide carbonic anhydrase (CA, EC 126.96.36.199) inhibitor dorzolamide (DRZ), a new sulfonamide CA inhibitor also incorporating NO-donating moieties, NCX250, and isosorbide mononitrate (ISMN) (an NO-donating compound with no CA inhibitory properties) were investigated for their intraocular pressure (IOP) lowering effects in rabbits with carbomer-induced glaucoma. "
03/01/1997 - "To study the pharmacokinetics of nicotine complexed with a polyacrylic carbomer and administered by enema to eight healthy volunteers and to eight patients with active ulcerative colitis, verified sigmoidoscopically. "
06/01/1998 - "We have previously developed a topical enema combining nicotine with a polyacrylic carbomer; pharmacokinetic parameters were similar in healthy volunteers and patients with active ulcerative colitis. "
03/01/1997 - "Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis."
|2.||Suppositories (Vaginal Suppositories)
|8.||Hyaluronic Acid (Hyaluronan)
|9.||Anti-Bacterial Agents (Antibiotics)
|10.||alginic acid (sodium alginate)